MAZE – maze therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Maze Therapeutics (NASDAQ:MAZE) had its price target raised by analysts at BTIG Research from $37.00 to $46.00. They now have a "buy" rating on the stock.
Maze Therapeutics: An Innovative, Nature-Driven Platform [Seeking Alpha]
What to Know About One Maze Insider's $3 Million Stock Sale as Shares Surge 150% [Yahoo! Finance]
Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Form 144 Maze Therapeutics, Inc. Filed by: Kathiresan Sekar
Form 4 Maze Therapeutics, Inc. For: Jan 07 Filed by: Bernstein Harold
Form 4 Maze Therapeutics, Inc. For: Jan 06 Filed by: Sohn Catherine A.
Form 144 Maze Therapeutics, Inc. Filed by: Sohn Catherine A.
Form 144 Maze Therapeutics, Inc. Filed by: Sohn Catherine A.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.